falsefalse

The Role of Tyrosine Kinase Inhibitors in Unresectable Hepatocellular Carcinoma - Episode 4

HCC Trials: Insights from the LAUNCH, EMERALD-1, and LEAP-012 Trials

,

Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    x